Recall Register

Magellan Diagnostics, Inc.: FDA recalls

Newest recall start date in this list: . LeadCare II Blood Lead Test Kit. Model/Catalog Number: 70-6762.

FDA enforcement events from 2014 to 2026; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name Magellan Diagnostics, Inc. as the recalling firm in 10 events. The events have 17 product records. The recalls started from 2014 to 2026. All the events are device recalls. By FDA enforcement events, Magellan Diagnostics, Inc. is number 352 of 1,629 firms that have a page. Events that Magellan Diagnostics, Inc. started: 1 in 2024 and none in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025. Class II is 60.0% of its events and 73.7% of all FDA events.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

10 events, newest first.

FDA enforcement events of Magellan Diagnostics, Inc.
InitiatedProduct (first record)TypeClassRecordsStatus
4 Sep 2026LeadCare II Blood Lead Test Kit. Model/Catalog Number: 70-6762.DeviceClass III1Ongoing
13 Mar 2026(1)(2) LeadCare II Blood Lead Test Kit, (3)LeadCare II 5X Blood Lead Test Kit, (4)LeadCare II 9X Blood Lead Test Kit; Catalog Number(s): (1) 70-6762, (2) 70-6762RUO, (3) 70-8404 (Box containing 5 Test Kits), (4) 70-9000 (Box containing 9 test kits); The LeadCare II kit is provided with the following materials: "…DeviceClass II3Ongoing
23 Feb 2024The LeadCare II Blood Lead Test System relies on electrochemistry and a unique Sensor to detect lead in whole blood. The LeadCare II Test Kit is provided with the following materials: " Sensors (2 Containers of 24 sensors each; 48 tests) " Treatment Reagent Tubes (2 packages of 24 tubes each; 48 tests) "…DeviceClass II1Ongoing
19 Sep 2023LeadCare II Blood Lead Test Kit-For in vitro diagnostic use only. The test kit is for the quantitative measurement of lead in capillary whole blood.DeviceClass II1Ongoing
7 May 2021LeadCare II Blood Lead Test Kit Catalog Number 70-6762DeviceClass I3Terminated
8 Aug 2018Magellan LeadCare II Blood Lead Test Kit. In Vitro Test for the measurement of lead in fresh whole blood. Catalog Number: 70-6762 Primary DI No: 00850355006000 The LeadCare II Blood Lead Test Kit is for in vitro diagnostic use only. The test kit is for the quantitative measurement of lead in fresh whole blood. This…DeviceClass II1Terminated
9 Jan 2018LeadCare II Blood Lead Analyzer Part Numbers: 70-6760, 70-6529-R, 70-6760-P, 70-6760-R. Intended for in vitro (external) use only.DeviceClass II2Terminated
23 May 2017Magellan Diagnostics LeadCare and LeadCare II test Kits. Product Usage: The LeadCare Blood Lead Test Kit is for in vitro diagnostic use only. The Test Kit is for the quantitative measurement of lead in fresh whole blood. This product is for professional use only. Sensors and Treatment Reagent of the Test Kit are…DeviceClass I2Terminated
20 Jan 2016LeadCare II Blood Lead Test Kit, containing LeadCare II Lead Controls Product Usage: IVD test kit for the detection of lead in blood. The kit consists of sensors, treatment reagent, lead controls (two levels), heparinized capillary tubes and plungers, transfer droppers and a calibration button. The LeadCare II Lead…DeviceClass II1Terminated
29 Nov 2014Magellan Diagnostics LeadCare Ultra Blood Analyzer Part Number: 80-0010DeviceClass I2Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

Magellan Diagnostics, Inc.: events for each product type
TypeEvents
Device10
Magellan Diagnostics, Inc.: events in each class
ClassEvents
Class II6
Class I3
Class III1
Share of the events of the firm in Class I
30%
Share of all events on the register in Class I
18%
Events with the status Ongoing
4

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of Magellan Diagnostics, Inc., by the year that the recall started. The largest year is 2018, with 2 events.

Official channels

Cite this page

Recall Register. Magellan Diagnostics, Inc.: FDA recalls. https://recallregister.com/firm/magellan-diagnostics-inc/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
State of the firm address
MA

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of Magellan Diagnostics, Inc. have?
Class II: 6 events. Class I: 3 events. Class III: 1 event. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of Magellan Diagnostics, Inc.?
FDA event 99776, which the firm started on 4 Sep 2026. The first product in the record is: LeadCare II Blood Lead Test Kit. Model/Catalog Number: 70-6762.
How many FDA recalls of Magellan Diagnostics, Inc. have the status Ongoing?
4 events have the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.